{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "345",
                "351"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "NUKKCz"
        },
        {
            "identifier": "T2",
            "position": [
                "354",
                "365"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "25.01.2018r"
        },
        {
            "identifier": "T3",
            "position": [
                "368",
                "376"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Enarenal"
        },
        {
            "identifier": "T4",
            "position": [
                "378",
                "381"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "ANA"
        },
        {
            "identifier": "T5",
            "position": [
                "383",
                "401"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "czopek glicerynowy"
        },
        {
            "identifier": "T6",
            "position": [
                "554",
                "623"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Wrodzona wada serca pod postaci\u0105 ubytku w przegrodzie mi\u0119dzykomorowej"
        },
        {
            "identifier": "T7",
            "position": [
                "628",
                "661"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Niedokrwisto\u015b\u0107 z niedoboru \u017celaza"
        },
        {
            "icd": "ICD10:Q21.0",
            "identifier": "N1",
            "referenced": "T6",
            "subtype": "Reference",
            "type": "N",
            "value": "Ubytek przegrody mi\u00c4\u0099dzykomorowej"
        },
        {
            "icd": "ICD10:D50",
            "identifier": "N2",
            "referenced": "T7",
            "subtype": "Reference",
            "type": "N",
            "value": "Niedokrwisto\u00c5\u009b\u00c4\u0087 z niedoboru \u00c5\u00bcelaza"
        },
        {
            "arg1": "T2",
            "arg2": "T1",
            "identifier": "R1",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T2",
            "arg2": "T3",
            "identifier": "R2",
            "subtype": "Dat",
            "type": "R"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 4 miesi\u0119cy\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: \u017ce\u0144ska\n------------------------------------------------\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nNUKKCz - 25.01.2018r,  Enarenal, ANA, czopek glicerynowy.\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpoznanie IV: |Opisowo:: Wrodzona wada serca pod postaci\u0105 ubytku w przegrodzie mi\u0119dzykomorowej.\\x0aNiedokrwisto\u015b\u0107 z niedoboru \u017celaza.\\x0a/Q 21.0; D 50/|Rozpoznanie III: |Rozpozanie I: ICD10:Q21.0|Rozpoznanie V: |Rozpoznanie II: ICD10:D50\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nPotas: K:4.80[mmol/L]\nPotas: K:5.00[mmol/L]\nS\u00f3d: Na:138.00[mmol/L]\nS\u00f3d: Na:136.00[mmol/L]\nMorfologia\n    WBC:8.12[10\\\\^3/ul]\n    RBC:3.64[10\\\\^6/ul]\n    HGB:9.7[g/dl]\n    HCT:28.3[%]\n    MCV:77.7[fl]\n    MCH:26.6[pg]\n    MCHC:34.3[g/dl]\n    PLT:428.0[10\\\\^3/ul]\n    RDW-SD:35.2[fl]\n    RDW-CV:12.4[%]\n    PDW:11.6[fl]\n    MPV:10.6[fl]\n    P-LCR:28.8[%]\n    PCT:0.5[%]\n    NEUTR#:2.62[10\\\\^3/ul]\n    NEUTR%:32.3[%]\n    LYMPH#:4.37[10\\\\^3/ul]\n    LYMPH%:53.8[%]\n    MONO#:0.85[10\\\\^3/ul]\n    MONO%:10.50[%]\n    EO#:0.23[10\\\\^3/ul]\n    EO%:2.80[%]\n    BASO#:0.05[10\\\\^3/ul]\n    BASO%:0.60[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nMorfologia\n    WBC:4.47[10\\\\^3/ul]\n    RBC:4.73[10\\\\^6/ul]\n    HGB:12.5[g/dl]\n    HCT:36.8[%]\n    MCV:77.8[fl]\n    MCH:26.4[pg]\n    MCHC:34.0[g/dl]\n    PLT:328.0[10\\\\^3/ul]\n    RDW-SD:38.1[fl]\n    RDW-CV:13.3[%]\n    PDW:10.9[fl]\n    MPV:10.2[fl]\n    P-LCR:25.7[%]\n    PCT:0.3[%]\n    NEUTR#:1.29[10\\\\^3/ul]\n    NEUTR%:28.8[%]\n    LYMPH#:2.27[10\\\\^3/ul]\n    LYMPH%:50.8[%]\n    MONO#:0.77[10\\\\^3/ul]\n    MONO%:17.20[%]\n    EO#:0.11[10\\\\^3/ul]\n    EO%:2.50[%]\n    BASO#:0.03[10\\\\^3/ul]\n    BASO%:0.70[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nABL Parametry krytyczne\n    pH:7.400\n    pCO2:33.3[mmHg]\n    BE:-3.30[mmol/L]\n    HCO3:20.2[mmol/L]\n    pO2:60.7[mmHg]\n    O2Sat:92.8[%]\n    Na - ABL:139[mmol/L]\n    K - ABL:4.1[mmol/L]\n    Cl - ABL:110[mmol/L]\n    Ca zj ABL:1.28[mmol/L]\n    Ht - ABL:38.2[%]\n    Hb ABL:12.4[g/dl]\n    FO2Hb:91.0[%]\n    FCOHb:1.2[%]\n    FMetHb:0.7[%]\n    FHbF - ABL:0.00[%]\n    GLU-ABL:79[mg/dl]\n    mleczany:16[mg/dl]\n    COMMENT_HL7:\nImmununochemia -Immulite: COMMENT_HL7:\nFibrynogen (F): FIB:2.87[g/L]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:36.0[s]\nINR: INR:1.3\nCzas protrombinowy (PT): PT:14.3[s]\nCzas trombinowy (TT): TT:16.8[s]\nChlorki: Cl:102.00[mmol/L]\nChlorki: Cl:102.00[mmol/L]\nTransferyna: TRFRN:167.57[mg/dl]\nWap\u0144 ca\u0142kowity: Ca:2.71[mmol/L]\nMagnez: Mg:0.77[mmol/L]\nWska\u017anik wysycenia Fe %: wsk%Fe:17.07[%]\nUIBC-utajona zdolno\u015b\u0107 wi\u0105zania \u017celaza: UIBC:204.00[ug/dl]\nBilirubina ca\u0142kowita TBIL: TBIL:0.30[mg/dl]\nBia\u0142ko CRP: CRP:0.87[mg/dl]\nWska\u017anik PT: PT%:77[%]\nTIBC: TIBC:246.00[ug/dl]\nFe: Fe:42.00[ug/dl]\nKreatynina: CREA:0.30[mg/dl]\nMocznik: UREA:10.00[mg/dl]\nASPAT: AST:53.00[IU/L]\nASPAT: AST:52.00[IU/L]\nALAT: ALT:51.00[IU/L]\nALAT: ALT:50.00[IU/L]\nNT- proBNP: NTpBNP:1331.00[pg/ml]\nTroponina T: TnT hs:10.07[pg/ml]\nCK-MB aktywno\u015b\u0107: CK-MBakt.:32.00[IU/L]\nGlukoza w surowicy: GLU-sur:74[mg/dl]\nGlukoza w surowicy: GLU-sur:81[mg/dl]\nPosiew - Wymaz ze sk\u00f3ry: POSIEW:\nPosiew - Wymaz z odbytu: POSIEW:\nWzrost pacjenta: WzrostPac:62[cm]\neGFR (do 1r\u017c) wg Schwartza wsp. 0.413: eGFRdo1r\u017c:85.4[ml/min/1,73m2]\nImmunochemia - parametry krytyczne: COMMENT_HL7:\nPr\u00f3ba zgodno\u015bci (kontrola grupy krwi biorcy)\n    NR-KS:K18/000257\n    DONACJA:Z510018001096/C0\n    DONACJA:Z510618000161/C0\nGrupa krwi noworodkowa (do 4. m-ca \u017cycia)\n    BTA-IGG:- (ujemny)\n    NR-KS:G18/001566\nGrupa krwi noworodkowa (do 4. m-ca \u017cycia)\n    BTA-IGG:- (ujemny)\n    NR-KS:G18/001675\n------------------------------------------------\nICD10\n------------------------------------------------\nD50.9\nQ21.0\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n89.00\n89.602\n88.718\n88.761\n------------------------------------------------"
}